Pain News and Research

Latest Pain News and Research

UT Southwestern researchers identify common signaling mechanism that controls immune system

UT Southwestern Medical Center researchers have identified a common signaling mechanism to produce interferon - one of the main proteins used to signal the immune system when the body needs to defend itself against a virus, tumor, or other diseases.

15 Feb 2015

Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

Prime Healthcare announced today that it has completed its acquisition of St. Joseph Medical Center in Kansas City, MO, and St. Mary's Medical Center in Blue Springs, MO, as well as other assets of Carondelet Health from Ascension Health. St. Joseph and St. Mary's medical centers are acute-care hospitals with 456 beds and 900 physicians on staff combined.

14 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

Novel image-analysis technique improves breast cancer detection and diagnosis

Researchers at the University of Oklahoma have developed an image-analysis technique that is designed to improve breast cancer detection and diagnosis.

13 Feb 2015

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Throughout NSW, there are more than 6,000 children suffering from the extreme pain and fatigue of juvenile arthritis. Usually thought of as an ‘older persons’ disease, arthritis in children is a very real condition, and in extreme cases can even result in death.

13 Feb 2015

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, presented data demonstrating that obiltoxaximab (ETI-204) demonstrated a statistically significant survival benefit across a range of disease severity in animal model studies assessing treatment of inhalational anthrax, as well as effectiveness in post-exposure prophylaxis.

13 Feb 2015

Medflow 2.0 EHR, Release 10 gets ONC HIT 2014 Edition COMPLETE EHR certification

Medflow, Inc., Medflow 2.0 EHR, Release 10 has achieved ONC HIT 2014 Edition COMPLETE EHR certification, which designates that the software is capable of supporting Eligible Providers with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

13 Feb 2015

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20.

13 Feb 2015

Study shows how cannabidiol works within cells

A team of Stony Brook University researchers have identified fatty acid binding proteins (FABPs) as intracellular transporters for two ingredients in marijuana, THC and CBD (cannabidiol).

13 Feb 2015

Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal.

13 Feb 2015

Tips to help manage migraine in children

Although we may think of migraine as a disease of adults, it can also affect children of all ages. Some studies show migraine affects 6% of children and up to 28% of adolescents ages 15-17. To assist parents whose children suffer from migraine, and to help the children themselves, the American Migraine Foundation and its Chair, David W. Dodick, MD, FRCP (C) are offering a number of tips to help manage childhood migraine and minimize its impact.

12 Feb 2015

Peanut-shaped exercise ball promotes positive labor outcomes, reduces duration of delivery process

According to a new study by nurse researchers at Banner Good Samaritan Medical Center, a Phoenix hospital part of Banner Health, a peanut-shaped exercise ball can be a highly effective tool to accelerate the labor process for women with an epidural. The research shows women utilizing the peanut ball were half as likely to undergo a cesarean surgery and delivered babies faster than those who did not use the ball.

12 Feb 2015

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.

12 Feb 2015

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.

12 Feb 2015

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).

11 Feb 2015

Diamond Headache Clinic's Alexander Feoktistov named recipient of 2015 NHF Lectureship

The National Headache Foundation is pleased to announce that Alexander Feoktistov, M.D., Ph.D., Director of Research at Diamond Headache Clinic, Chicago, Illinois, has been named the recipient of the 2015 NHF Lectureship. As the premier educational and informational resource for those living with headache disorders, their family members, physicians, allied health professionals, and health policy decision makers, the NHF created this award to preserve the highest level of neurobiological research and advancement in medicine today.

11 Feb 2015

Carma Laboratories' NEW Carmex Cold Sore Treatment named 2015 'Product of the Year' winner

Carma Laboratories, Inc., the manufacturer of Carmex lip balm products, is pleased to announce that its NEW Carmex Cold Sore Treatment has been named the 2015 "Product of the Year" winner in the Specialty Skin Treatment category by Product of the Year USA – the nation's largest consumer survey on product innovation.

11 Feb 2015

IOM committee identifies five main symptoms to diagnose ME/CFS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome -- commonly referred to as ME/CFS -- is a legitimate, serious, and complex systemic disease that frequently and dramatically limits the activities of affected individuals, says a new report from the Institute of Medicine.

11 Feb 2015

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

10 Feb 2015

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease.

10 Feb 2015

Pain News and Research

Latest Pain News and Research

UT Southwestern researchers identify common signaling mechanism that controls immune system

Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Novel image-analysis technique improves breast cancer detection and diagnosis

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Medflow 2.0 EHR, Release 10 gets ONC HIT 2014 Edition COMPLETE EHR certification

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Study shows how cannabidiol works within cells

Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Tips to help manage migraine in children

Peanut-shaped exercise ball promotes positive labor outcomes, reduces duration of delivery process

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Diamond Headache Clinic's Alexander Feoktistov named recipient of 2015 NHF Lectureship

Carma Laboratories' NEW Carmex Cold Sore Treatment named 2015 'Product of the Year' winner

IOM committee identifies five main symptoms to diagnose ME/CFS

DePuy Synthes announces acquisition of Olive Medical

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in